UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Cambridge Trust Co.

Cambridge Trust Co. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 84,503 shares of the healthcare conglomerate’s stock after acquiring an additional 187 shares during the period. UnitedHealth Group makes up about 1.9% of Cambridge Trust Co.’s investment portfolio, making the stock its 12th largest position. Cambridge Trust Co.’s holdings in UnitedHealth Group were worth $44,488,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. Robbins Farley purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $25,000. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. CGC Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. NewSquare Capital LLC lifted its holdings in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its holdings in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH traded up $17.19 during trading hours on Thursday, reaching $496.18. The company had a trading volume of 5,578,961 shares, compared to its average volume of 4,480,536. The stock has a 50-day moving average of $489.51 and a two-hundred day moving average of $515.38. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The firm has a market capitalization of $457.44 billion, a PE ratio of 30.39, a PEG ratio of 1.28 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.26 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on UNH shares. Wells Fargo & Company reduced their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday. Barclays boosted their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday. Bank of America reiterated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $569.68.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.